Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Sixty-Five Percent Report Some Pain 1 Year After Surgery

Most women feel some level of pain 1 year after breast cancer surgery, Finnish researchers found. They hope their findings, published in the Journal of the American Medical Association, help inspire new ways of preventing and treating pain to improve quality of life after surgery.

News From the San Antonio Breast Cancer Symposium

Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.

Women Report Positive Life Changes After Challenge of Breast Cancer

Despite anxiety that can arise from a breast cancer diagnosis, a recent study shows that in the year that follows women may experience post-traumatic growth, or positive changes to the way they view relationships, themselves or their lives. 

Heavy Weightlifting Safe for Women With Lymphedema, Study Suggests

Women with lymphedema — swelling in the arm caused by the surgical removal of lymph nodes or by damage to the lymph nodes from radiation therapy for breast cancer — may perform upper-body strength training exercises with light and heavy weights, without worsening swelling or other lymphedema symptoms, Australian researchers say.

FDA Grants Accelerated Approval of Pre-Surgery Pertuzumab Regimen

Genentech, a developer of medicine, announced September 30 that the U.S. Food and Drug Administration granted accelerated approval of the company’s medicine pertuzumab (Perjeta)—in combination with trastuzumab (Herceptin) and docetaxel—as pre-surgery treatment for those with high-risk, HER2-positive, inflammatory, early-stage or locally advanced breast cancer. 

Labels May Affect Decision-making for Breast Lesions

NEW YORK (Reuters Health) - How doctors describe a non-invasive type of breast lesion may affect how women choose to have the abnormal cells treated, a new survey suggests.

Delayed Time to Surgery Reduces Survival Rates in Young Women

Young women whose surgery-only breast cancer treatment is delayed longer than 6 weeks have decreased survival rates compared with women who are treated sooner.

Young Women More Often Choose Mastectomy Over Lumpectomy

Young women who have a choice of surgical treatment choose mastectomy more often than lumpectomy, or breast-conserving treatment, according to a study presented at a major breast cancer conference.

Study Supports Use of Zoledronic Acid for Early Breast Cancer

Researchers found that postmenopausal women who started taking zoledronic acid when they began treatment with the aromatase inhibitor letrozole saw improved bone strength in the spine and hip compared with women who started zoledronic acid after their bone density dropped too low.

Trastuzumab Recommended for HER2 Positive, Invasive Lobular Breast Cancer

Women diagnosed with early-stage breast cancer that begins in the lobules of the breast gain just as much benefit from treatment with trastuzumab (Herceptin) as women with early-stage cancer that starts in the ducts of the breast, researchers found. 

Join Your Community for Yoga on the Steps!

Close
close